INNATE PHARMA S A's ticker is IPHA and the CUSIP is 45781K204. A total of 13 filers reported holding INNATE PHARMA S A in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $113,734 | -21.4% | 44,954 | -4.5% | 0.00% | – |
Q2 2023 | $144,676 | +4.2% | 47,049 | -3.4% | 0.00% | – |
Q1 2023 | $138,858 | -24.6% | 48,722 | -1.3% | 0.00% | – |
Q4 2022 | $184,138 | +61.5% | 49,367 | -13.2% | 0.00% | – |
Q3 2022 | $114,000 | -9.5% | 56,852 | +22.0% | 0.00% | – |
Q2 2022 | $126,000 | -16.6% | 46,598 | +3.7% | 0.00% | – |
Q1 2022 | $151,000 | -16.1% | 44,954 | +14.3% | 0.00% | – |
Q4 2021 | $180,000 | +65.1% | 39,330 | +121.8% | 0.00% | – |
Q3 2021 | $109,000 | -9.9% | 17,729 | -51.6% | 0.00% | – |
Q2 2021 | $121,000 | -50.0% | 36,630 | -34.7% | 0.00% | – |
Q1 2021 | $242,000 | +1052.4% | 56,110 | +993.8% | 0.00% | – |
Q4 2020 | $21,000 | +250.0% | 5,130 | +226.5% | 0.00% | – |
Q3 2020 | $6,000 | -92.9% | 1,571 | -87.4% | 0.00% | – |
Q2 2020 | $85,000 | +286.4% | 12,441 | +277.0% | 0.00% | – |
Q1 2020 | $22,000 | – | 3,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rubric Capital Management LP | 931,673 | $6,382,000 | 0.73% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 500,000 | $3,425,000 | 0.01% |
WELLINGTON MANAGEMENT GROUP LLP | 1,351,538 | $9,866,000 | 0.00% |
MILLENNIUM MANAGEMENT LLC | 72,657 | $530,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
MORGAN STANLEY | 12,441 | $85,000 | 0.00% |
Steward Partners Investment Advisory, LLC | 1,100 | $8,000 | 0.00% |
OSAIC HOLDINGS, INC. | 2,000 | $14,000 | 0.00% |